Friday, August 27, 2021 6:55:06 AM
https://pulse2.com/nrx-pharmaceuticals-nasdaq-nrxp-stock-over-16-increase-explanation/
“As the COVID-19 pandemic continues, so does the need for more innovative, effective and FDA-approved therapies for critically-ill patients with respiratory failure. Cardinal Health is pleased to ensure that COVID-19 patients get access to treatment in a timely and efficient manner.” — Marc DeLorenzo, Senior Vice President of Strategic Sourcing at Cardinal Health ——— Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM